Art

J-GLOBAL ID：201102234618595421   Reference number：11A1146674

Association of fluoropyrimidines, platinum agents, taxanes, and irinotecan in any line of chemotherapy with survival in patients with advanced gastric cancer

いずれかの薬物治療ラインにおけるフッ化ピリミジン,白金製剤,タキサン類,およびイリノテカンの使用と進行胃癌の予後の関連性

Author (13)： SHITARA Kohei (Aichi Cancer Center Hospital, Aichi, JPN) ,  MATSUO Keitaro (Aichi Cancer Center Res. Inst., Nagoya, JPN) ,  MIZOTA Ayako (Aichi Cancer Center Hospital, Aichi, JPN) ,  KONDO Chihiro (Aichi Cancer Center Hospital, Aichi, JPN) ,  NOMURA Motoo (Aichi Cancer Center Hospital, Aichi, JPN) ,  TAKAHARI Daisuke (Aichi Cancer Center Hospital, Aichi, JPN) ,  YOKOTA Tomoya (Aichi Cancer Center Hospital, Aichi, JPN) ,  URA Takashi (Aichi Cancer Center Hospital, Aichi, JPN) ,  ITO Seiji (Aichi Cancer Center Hospital, Aichi, JPN) ,  SAWAKI Akira (Aichi Cancer Center Hospital, Aichi, JPN) ,  TAJIKA Masahiro (Aichi Cancer Center Hospital, Aichi, JPN) ,  KAWAI Hiroki (Aichi Cancer Center Hospital, Aichi, JPN) ,  MURO Kei (Aichi Cancer Center Hospital, Aichi, JPN)
Material： Gastric Cancer
Volume： 14  Issue： 2  Page： 155-160  Publication year： 2011 
JST Material Number： L7803A  ISSN： 1436-3291  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： Taxanes ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A1146674&from=J-GLOBAL&jstjournalNo=L7803A") }}

JST classification (2)： Tumors(=neoplasms)of digestive system  (GH04000D) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Substance index (3)： Fluorouracil ,  Paclitaxel ,  Irinotecan

Reference (19)：

• 1. International Agency for Research on Cancer GLOBOCAN 2008. http://www-dep.iarc.fr/CancerMondial.htm.
• 2. Van Cutsem E, Moiseyenko VM, Tjulandin S, Maths A, Cons-tenla M, Boni C, et al. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol. 2006;24:4991-7.
• 3. Cunningham D, Starling N, Rao S, Iveson T, Nicolson M, Coxon F, et al. Capecitabine and oxaliplatin for advanced esophagoga-stric cancer. N Engl J Med. 2008;358:36-46.
• 4. Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, et al. S-1 plus cisplatm versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9:215-21.
• 5. Kang YK, Kang WK, Shin DB, Chen J, Xiong J, Wang J, et al. Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial. Ann Oncol. 2009;20:666-73.

Terms in the title (8)： 薬物治療 ,  ピリミジン ,  白金製剤 ,  タキサン類 ,  イリノテカン ,  進行胃癌 ,  予後 ,  関連性